[1]
J. J. Borg, “Where is Industry Getting it Wrong? A Review of Quality Concerns Raised at Day 120 by the Committee for Medicinal Products for Human Use during European Centralised Marketing Authorisation Submissions for Chemical Entity Medicinal Products”, J Pharm Pharm Sci, vol. 12, no. 2, pp. 181–198, Aug. 2009.